Assessment of the specificity of norethisterone radioimmunoassays. 1978

N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy

UI MeSH Term Description Entries
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
March 1973, Clinica chimica acta; international journal of clinical chemistry,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
June 1979, The Journal of endocrinology,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
July 1983, The British journal of dermatology,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
January 1975, Journal of steroid biochemistry,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
January 1979, Journal of steroid biochemistry,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
July 1979, Journal of steroid biochemistry,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
January 1992, Journal of chromatography,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
December 1979, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
November 1975, The Journal of endocrinology,
N Bedolla-Tovar, and S A Rahman, and S Z Cekan, and E Diczfalusy
January 1983, Urologia internationalis,
Copied contents to your clipboard!